CIK 0001540171 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Avalyn Pharma Inc.
Sign in to watch- Ticker
- AVLN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452463191
- Phone
- (206) 707-0340
- Business address
- 105 W FIRST ST., BOSTON, MA, 02127
- Former names
- Genoa Pharmaceuticals, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- CERT Other Certification
- S-1/A Offering Registration Statement
- 8-A12B Other Registration of Securities
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
Page 3 of 4 · 66 filings